Clinical Trial Update: Study to Evaluate the Effect of Nicotinamide Riboside on Immunity [NA]

View source ↗

Summary

Clinical trial evaluating nicotinamide riboside for immunity in adults with atherosclerosis and diabetes; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease
• Diabetes

Drugs mentioned

• Nicotinamide Riboside (nicotinamide riboside)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Atherosclerosis, Diabetes | NA | Status: COMPLETED | Results posted: 2019-09-17